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Abstract 1	  
 2	  
Antimicrobial resistant Klebsiella pneumoniae (Kp) has emerged as a major global 3	  
public health problem. While resistance can occur across a broad range of Kp clones, 4	  
a small number have become globally distributed and commonly cause outbreaks in 5	  
hospital settings. Here we describe recent comparative genomics investigations that 6	  
have shed light on Kp population structure and the evolution of antimicrobial resistant 7	  
clones. These studies provide the basic framework within which genomic 8	  
epidemiology and evolution can be understood, but have merely scratched the surface 9	  
of what can and should be explored. We assert that further large-scale comparative 10	  
and functional genomics studies are urgently needed to better understand the biology 11	  
of this clinically important bacterium. 12	  
  13	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Klebsiella pneumoniae Is a Major Public Health Threat 14	  
 15	  
K. pneumoniae (Kp) is a Gram-negative bacteria belonging to the family 16	  
Enterobacteriaceae. Closely related to the well-known pathogens Salmonella enterica 17	  
and Escherichia coli, Kp can colonise a similarly wide range of animal hosts, but can 18	  
also be found in association with plants; in soil, water and drains; and colonising a 19	  
diversity of body sites including the respiratory tract, gut, nasopharynx, oropharynx 20	  
and skin [1,2]. Kp is considered an opportunistic pathogen, with the majority of 21	  
infections occurring in neonates, the elderly and the immunocompromised [2]. 22	  
Urinary tract infection (UTI), pneumonia and wound or soft tissue infections are the 23	  
most common disease syndromes. Kp has been amongst the most frequent agents 24	  
causing hospital-acquired infections in all settings for many decades [2,3]. It is the 25	  
‘K’ in the ESKAPE pathogens, the six most significant and dangerous causes of drug 26	  
resistant hospital infections identified by the Infectious Diseases Society of America 27	  
[4]. More recently, Kp has been recognised by the World Health Organization, 28	  
Centers for Disease Control and Prevention, European Union and other organisations 29	  
as a significant threat to global public health due to its high rates of antimicrobial 30	  
resistance (AMR) (see [5] and www.cdc.gov/drugresistance/pdf/ar-threats-2013-31	  
508.pdf). This increased attention is largely due to the increasing occurrence of high-32	  
profile hospital outbreaks and deaths associated with a particular AMR clone 33	  
producing the Kp carbapenemase (KPC). However it is also associated with the role 34	  
of Kp as the ‘canary in the coalmine’ – the organism in which most new AMR genes 35	  
to be discovered in the last two decades were first detected, before becoming 36	  
widespread in Gram-negative bacterial pathogens [including the extended spectrum 37	  
beta-lactamase (ESBL) forms of SHV [6] and CTX-M [7]; the carbapenemases KPC 38	  
[8] and NDM [9]; and most recently MCR-1 [10], the first plasmid-borne gene to be 39	  
associated with colistin resistance] 40	  
 41	  
The emergence of AMR Kp as a major global health problem has coincided with the 42	  
establishment of whole genome sequencing as a viable tool for investigating and 43	  
tracking bacterial pathogens, thanks to the development of cost-effective high 44	  
throughput sequencing. Genomic comparisons can offer a high-resolution view of 45	  
genetic variation at whole-genome scale and can be applied to explore the diversity of 46	  
pathogen populations, the evolution of clinically important traits such as AMR, and 47	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patterns of disease transmission and dissemination. Here we review recent insights 48	  
into the population structure of Kp and the evolution of AMR clones gleaned from 49	  
genomic studies; outline current tools available for genomic investigation of Kp; and 50	  
identify outstanding questions concerning the problem of AMR Kp that would benefit 51	  
from further application of genomics. 52	  
 53	  
Population Structure and Genome Variation 54	  
The population structure of Kp has been elucidated using various DNA sequencing 55	  
approaches. A Kp multi-locus sequence typing (MLST) scheme, targeting seven 56	  
chromosomally encoded housekeeping genes, was established in 2005 [11,12]. MLST 57	  
provides a standardised reproducible system for strain identification and nomenclature 58	  
for a given species [13]. The Kp MLST scheme has been widely adopted and has been 59	  
centrally important to the identification and investigation of clinically important 60	  
phylogenetic lineages, which are typically referenced by their sequence type (ST; e.g. 61	  
ST258). The availability of high throughput whole genome sequencing has since 62	  
afforded much deeper resolution of the Kp population. In 2014, the MLST approach 63	  
was extended to a core gene MLST (cgMLST) scheme targeting 694 core genes, 64	  
which can be used to define high-resolution STs and their aggregation into clonal 65	  
groups (CGs) [14]. The publicly available cgMLST database for Kp is hosted at the 66	  
Institut Pasteur using the BIGSdb platform [15]. It now includes the seven-locus 67	  
MLST scheme, which still forms the basis for the nomenclature of clinically 68	  
important Kp CGs (e.g. CG258 designates the clonal group that includes ST258). Kp 69	  
genome data can also be interrogated using phylogenetic analysis of single nucleotide 70	  
polymorphisms (SNPs) across the whole genome [16,17]. In addition to identifying 71	  
phylogenetic lineages or CGs, this approach can provide a very high-resolution view 72	  
of recent evolution within CGs, which can be particularly useful for investigating 73	  
local Kp outbreaks and global dissemination patterns [14,17–24]. 74	  
 75	  
Isolates identified as K. pneumoniae using standard biochemical or proteomics tests 76	  
typically include three phylogenetically distinct groups or phylogroups that were 77	  
originally designated KpI, KpII and KpIII but have now been designated as distinct 78	  
species K. pneumoniae, Klebsiella quasipneumoniae and Klebsiella variicola, 79	  
respectively [16,25,26]. All three are covered by the same MLST and cgMLST 80	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schemes, which can be used to differentiate the species [11,12]. Whole genome 81	  
sequence comparison has shown that these groups are distinguished by 3-4% average 82	  
nucleotide divergence across the core genome, hardly ever recombine, and can be 83	  
differentiated on the basis of gene content, indicating that they represent distinct 84	  
independently-evolving populations and supporting their recognition as distinct 85	  
species [16]. For the remainder of this review, the term K. pneumoniae (Kp) will be 86	  
used to refer strictly to K. pneumoniae (i.e. the KpI phylogroup). 87	  
 88	  
The Kp population is comprised of numerous deep-rooted phylogenetic lineages 89	  
radiating from a single common ancestor (Figure 1a), with approximately 0.5% 90	  
average nucleotide divergence between lineages [12,16]. These lineages show 91	  
evidence of occasional homologous recombination [11,12,16,27,28] but estimates of 92	  
r/m (the relative probability that a nucleotide change resulted from recombination vs 93	  
point mutation) based on limited MLST data have yielded conflicting results [12,29]. 94	  
Further investigation of recombination dynamics based on whole genome data is 95	  
warranted, however the overall population structure appears to be relatively clonal. 96	  
 97	  
A total of 157 lineages were reported based on whole genome analysis of a diverse 98	  
collection of 289 Kp genomes [16] and 155 CGs are currently defined in the public 99	  
cgMLST database [14], however the rate of discovery of new lineages suggests that 100	  
the total number in existence far exceeds this, likely reaching the thousands (Figure 101	  
1b). The long-term persistence of so many distinct Kp lineages has yet to be 102	  
explained. Kp occupies a wide range of ecological niches including many non-host 103	  
associated environments [1,2,16,26]. Extensive exopolysaccharide diversity has been 104	  
described, but this is not generally associated with phylogenetic lineage. Only 12 O 105	  
antigen serotypes have been identified in Kp, each of which are shared by diverse 106	  
lineages [30]. Kp capsular variation is more extensive: 77 phenotypically defined 107	  
capsular serotypes are recognised [31–33], and genetic studies of capsule biosynthesis 108	  
(K) loci indicate the existence of twice this number [18,27,28,30,34,35]. A single 109	  
capsular serotype can be found in numerous distinct Kp lineages and extensive 110	  
capsular diversity has been identified within lineages, resulting from horizontal 111	  
transfer and recombination of K locus genes [12,14,16,28,30]. 112	  
 113	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The average Kp genome is 5.5 Mbp in size and encodes ~5,500 genes. Whole genome 114	  
comparisons of hundreds of isolates indicate that the core genome, that is the set of 115	  
genes that are common to all Kp, includes fewer than 2,000 genes [14,16]. The 116	  
additional 3,500 ‘accessory’ genes in each genome are drawn from a pool of more 117	  
than 30,000 protein-coding genes (using a cut-off of >30% amino acid divergence to 118	  
define a new gene; or >70,000 using a cut-off of >10% amino acid divergence) [16]. 119	  
The rate of accumulation of Kp accessory genes with increasing genome sequences 120	  
indicates the Kp population has an open pan genome [36], meaning that Kp has access 121	  
to a vast gene pool (Figure 2a). Assignment of Kp accessory genes to functional 122	  
groups identified common functions including carbohydrate metabolism (19%), other 123	  
metabolic pathways (18%), membrane transport (13%), exopolysaccharide capsule 124	  
(11%), iron resistance and metabolism (2%) and resistance to antibiotics, heavy 125	  
metals and stress (1%); a third of protein-coding genes found in Kp have as-yet 126	  
unknown functions [16]. Although there is evidence that individual accessory genes 127	  
can be distributed across multiple phylogenetic lineages, each lineage is associated 128	  
with a distinct complement of genes that differs from that of other lineages (see 129	  
Figure 2b) [16]. It is therefore likely that different Kp strains vary substantially in 130	  
their metabolic capacity, which may account for the wide array of ecological niches in 131	  
which Kp is found and also the persistence of distinct chromosomal lineages, which 132	  
could potentially differ quite substantially from one another in terms of the range of 133	  
niches that they can readily inhabit. Furthermore, there is evidence that the circulation 134	  
of highly mobile accessory genes within the Kp population, via plasmids and other 135	  
conjugative elements, may contribute to survival of Kp in different niches [16,37–39]. 136	  
A recent genomic analysis found the presence of a plasmid-encoded lac (lactose 137	  
utilisation) operon, identified in ~50% of sequenced Kp isolates, was significantly 138	  
associated with Kp isolated from dairy cows with mastitis, while the presence of 139	  
plasmid-encoded aerobactin, a siderophore that promotes growth in blood by 140	  
removing iron from high affinity sites on human transferrin [40], was associated with 141	  
Kp isolated from bacteraemia and other invasive infections in humans [16]. 142	  
 143	  
AMR Determinants 144	  
Kp is intrinsically resistant to ampicillin due to the presence of the SHV beta-145	  
lactamase in the core genome (note K. quasipneumoniae and K. variicola carry highly 146	  
divergent forms of this beta-lactamase known as OKP and LEN [16]). Comparative 147	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genomic analysis indicates that fosA and the efflux pump oqxAB, which confer low-148	  
level resistance to fosfomycin and the quinolone nalidixic acid, are also core genes in 149	  
K. pneumoniae, K. quasipneumoniae and K. variicola [16]. However the majority of 150	  
AMR in Kp results from the acquisition of AMR genes via horizontal transfer, mainly 151	  
carried by plasmids [41]. More than 100 distinct acquired AMR genes have been 152	  
identified in Kp [16] (Table 1), and hundreds of AMR-associated plasmids belonging 153	  
to dozens of distinct rep types (plasmid replication machinery types) have been 154	  
reported [16,37,41]. It is not uncommon for individual Kp strains to carry multiple 155	  
plasmids, and for several of these to contain distinct sets of AMR genes, resulting in 156	  
resistance to nearly all available antimicrobials [21,23,37,42]. Direct transfer of AMR 157	  
plasmids between distinct Kp strains, and between Kp and other Enterobacteriaceae, 158	  
has been detected in whole genome sequencing studies of hospitalised patients and in 159	  
hospital environments, presumably driven by selection from exposure to a range of 160	  
antimicrobials [42–44]. 161	  
 162	  
Of particular clinical concern are the dissemination of carbapenemase genes KPC, 163	  
OXA-48 and NDM-1, and the ESBL gene CTX-M-15. Each of these genes is 164	  
associated with a specific transposon that mobilises it between different plasmid 165	  
backbones (which can then spread to other strains and species) and sometimes into the 166	  
Kp chromosome itself [45–47]. All four genes have been reported in diverse Kp 167	  
lineages. KPC is associated with a broad range of plasmids and is mobilised by 168	  
Tn4401, a 10 kbp Tn3-like transposon, for which there are five known isoforms 169	  
[48,49]. KPC was intimately linked with the emergence of ST258 and its derivative 170	  
ST512 (see below), but has become more widely disseminated [45,50,51] . OXA-48 is 171	  
mobilised by Tn1999 and is most commonly, but not exclusively, associated with 172	  
IncL/M plasmids [52–55]. NDM-1 is found in a broad range of plasmids of distinct 173	  
rep types but its mechanism of mobilisation is less certain [9]. Complete or truncated 174	  
ISAba1 is often found upstream of NDM-1, suggesting at least an historical role for 175	  
this insertion sequence (IS) [9,54]. However, there is also evidence of alternative 176	  
mobilisation e.g. via IS26 or ISCR1 [56,57]. CTX-M-15 is mobilised by ISEcp1 and 177	  
in Kp is most commonly associated with IncFII plasmids that simultaneously carry 178	  
other AMR genes [20,21,58–60]. 179	  
 180	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Mutational resistance can also occur in Kp. Induced expression of intrinsic efflux 181	  
pumps such as those encoded by acrAB and oqxAB have been associated with reduced 182	  
susceptibility to tigecycline, fluoroquinolones and other antimicrobials [61,62]. 183	  
Reduced permeability of the outer membrane via functional loss of the outer 184	  
membrane porins encoded by ompK35 and ompK36 can cause resistance to extended 185	  
spectrum cephalosporins and reduced susceptibility to carbapanems and 186	  
fluoroquinolones [63]. Fluoroquinolone resistance is often conferred by a combination 187	  
of substitutions in the genes encoding the topoisomerase targets, GyrA and ParC 188	  
[64,65]. The presence of these mutations and of acquired AMR plasmids do not 189	  
necessarily reduce fitness in terms of competitive growth or efficiency of transmission 190	  
between patients [39,66,67], consequently both are often encountered on first 191	  
isolation rather than evolving in vivo during treatment. In areas where fluoroquinolone 192	  
and carbapenem resistance is common, treatment of Kp infections generally relies on 193	  
tigecycline or colistin [68]. Colistin resistance is rare upon first isolation but often 194	  
arises during treatment via mutations that upregulate the PhoQ/PhoP system and 195	  
pmrHFIJKLM operon, most commonly by inactivation of mgrB via IS insertions, but 196	  
also occasionally by deletions or nonsense mutations in this gene or others involved in 197	  
the same pathway [69–71]. Additional mechanisms of colistin resistance have 198	  
recently been reported, including mutations in the chromosomal crrB gene [72] and 199	  
acquisition of the plasmid-borne genes mcr-1 or mcr-1.2 [10,73]. It was initially 200	  
hoped that mgrB inactivation would compromise the ability of Kp to transmit and 201	  
cause infections in new hosts. However studies to date have found no fitness cost 202	  
during in vitro competitive growth [74] or animal models [75] and sustained 203	  
outbreaks of mgrB-mutant colistin resistant strains have been reported [76]. 204	  
Tigecycline resistance in Kp is usually caused by increased activity of the AcrAB 205	  
efflux pump via interruption of the regulators ramA, ramR or acrR [77–79]. A non-206	  
synonymous substitution in the rpsJ gene (encoding the S10 30S ribosomal subunit) 207	  
has also been implicated in tigecycline resistance [80]. 208	  
 209	  
Genomic Insights Into the Emergence of Antibiotic Resistant Clones 210	  
AMR has emerged within many distinct Kp and some K. variicola CGs [14,16,19,81], 211	  
however a small number have become widely disseminated and commonly cause 212	  
infections in a range of settings, despite the fact that they are not generally associated 213	  
with any of the known Klebsiella virulence determinants [14,16]. Figure 3 shows the 214	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geographical distribution of Kp outbreaks reported in the literature and associated 215	  
with a CG identified by MLST, as of 24th June 2016. These represent just the tip of 216	  
the iceberg of the global burden of Kp outbreaks, since most outbreaks are not 217	  
reported in the literature and MLST data are not ubiquitously generated. Notably, of 218	  
all reported outbreaks where MLST was performed, 72% identified one of five 219	  
common CGs (CG258, CG14/15, CG17/20, CG43, CG147, Figure 3). Twenty-two of 220	  
the remaining 24 outbreaks were associated with Kp STs, one was associated with K. 221	  
variicola (ST48 and its single locus variant, ST1236) and one was associated with K. 222	  
quasipneumoniae (ST334). Genomic investigations of some of these common CGs, or 223	  
‘clones’ are beginning to provide specific insights into their evolution. 224	  
 225	  
  226	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CG258 227	  
Undoubtedly the most widely recognised and globally distributed clone is CG258 228	  
(ST258, ST11, their single locus variants and other close relatives, e.g ST340, ST512, 229	  
ST437, ST833, ST855 and ST1199). ST258 is widely acknowledged as the major 230	  
cause of carbapenem-resistant Kp infections [48,82,83] and is predominantly 231	  
associated with the KPC-2 and KPC-3 carbapenemases. In contrast, other members of 232	  
this CG have been associated with a more diverse selection of carbapenemases and 233	  
ESBLs, including NDM-1, OXA-48 and CTX-M-15 [19,81,84–86]. The 234	  
epidemiology of CG258 has been well reviewed previously [48,49,82,83] so here we 235	  
focus on the most recent evolutionary insights from comparative genomic studies.  236	  
 237	  
An analysis of 319 Kp genomes, including 203 CG258 (predominantly ST258 and 238	  
ST11) suggested that a large genomic recombination event of ~1.3 Mbp length 239	  
distinguishes CG258 from its closest relatives [81] (Figure 4). This event was dated 240	  
to ~1985, suggesting that the most-recent common ancestor of CG258 was circulating 241	  
in the population at that time. ST258, ST340 and ST437 each form a single 242	  
monophyletic sub-clade within CG258, while ST11 is a paraphyletic group [19,28]. 243	  
ST258 arose from an ST11-like ancestor following a second large-scale genomic 244	  
recombination event, in which a ~1.1 Mbp genomic region was acquired from an 245	  
ST442 Kp [27,28]. The recombinant region included the K locus, which was distinct 246	  
from the ST11-like ancestor and presumably associated with a change of capsule 247	  
phenotype (Figure 4). Subsequently ST258 also acquired an integrative conjugative 248	  
element known as ICE258.2, which encoded a type IV pilus and a type III restriction 249	  
modification system [23,27]. It was speculated that the former may facilitate 250	  
improved adherence, while the latter may play a role in determining which plasmids 251	  
can be maintained within ST258 [23]. 252	  
 253	  
Early studies had suggested that ST258 was further divided into two distinct sub-254	  
lineages (I and II), distinguished by a third large-scale genomic recombination event 255	  
of ~215 kbp [23,87] (Figure 4). Again the recombinant region, which was acquired 256	  
from an ST42 Kp, included a distinct K locus [23,28]. Subsequently, Bowers and 257	  
colleagues showed that sub-lineages I and II actually form a monophyletic sub-clade 258	  
within ST258, and the remainder of the clade is paraphyletic [19]. Isolates from the 259	  
United States were distributed throughout; supporting the hypothesis that ST258 arose 260	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in that country, where it was first identified and remains highly prevalent [19,88]. 261	  
Further molecular dating analyses suggested the origin of ST258 circa 1995-1997 262	  
[19,81], just a few years before the first clinical reports [88,89].  263	  
 264	  
A total of 22 distinct K loci have now been associated with CG258, each of which 265	  
presumably imported by an independent recombination event [19,28]. The extensive 266	  
variability of this locus suggests that it is subject to strong diversifying selection, 267	  
although the drivers are as yet unclear. CG258 is also highly diverse in terms of 268	  
acquired AMR genes and chromosomal AMR-conferring variants, suggesting that 269	  
AMR has arisen independently multiple times, largely driven by the acquisition of a 270	  
diverse array of plasmids [19,22,23,42]. ST258 isolates typically harbour between two 271	  
and five plasmids of 10.9 kbp to 142.7 kbp [23,42]. The majority, although not all 272	  
[19,90], ST258 harbour at least one plasmid containing either KPC-2 or KPC-3. 273	  
pKpQIL is one such plasmid that is common among sub-lineages I and II [19], but 274	  
rare among the rest of the clade [22,23,42]. In fact, sub-lineages I and II are generally 275	  
associated with greater conservation of plasmids compared to the rest of the CG, 276	  
which is highly diverse [19]. Taken together, these genomic studies unravel a story of 277	  
a rapidly evolving, highly adaptive epidemic clone.  278	  
  279	  
CG14/15 280	  
CG14/15 is another globally distributed MDR clone [18,20,91–93]. Similar to 281	  
CG258, it has also been associated with a diverse array of AMR genes, including 282	  
those encoding ESBLs (in particular CTX-M-15 [18,20,94]) and carbapenemases 283	  
such as KPC [95], NDM-1 [18], OXA-48 [91], OXA-181 [93] and VIM-1 [92]. 284	  
Colistin resistance has been reported both with and without concomitant ESBL and/or 285	  
carbapenemase production [70,96]. 286	  
 287	  
Genomic analyses of ST15 isolates from The Netherlands and Nepal showed that they 288	  
can be divided into at least two sub-lineages, each associated with a distinct K locus 289	  
[18,20]. All of the Nepalese isolates harboured CTX-M-15, while 42 also harboured 290	  
NDM-1. The latter isolates were part of an outbreak from which nine NDM-1 291	  
negative isolates were also identified [18,21]. Long read SMRT sequencing of a 292	  
representative outbreak isolate identified four distinct plasmid replicons ranging from 293	  
69 kbp to 305 kbp. Three of the four plasmids contained AMR genes and/or heavy 294	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metal resistance genes. The fourth plasmid contained a tellurite resistance cassette. 295	  
The largest plasmid, pMK1-NDM, harboured NDM-1 in combination with CTX-M-296	  
15, OXA-1, aac(6’)-Ib-cr, aadA2, folP, catA1, dfrA12 and armA [21]. Short read 297	  
Illumina sequencing data suggested that all of the outbreak isolates harboured pMK1-298	  
NDM-like plasmids, including those that were NDM-1 negative due to deletion of the 299	  
NDM-1 region [18,21].   300	  
 301	  
Other Clonal Groups 302	  
Several other globally distributed MDR clones including CG17/20, CG43 and CG147 303	  
have been associated with a number of disease outbreaks (Figure 3). All were first 304	  
recognised in the mid-late 2000s and are associated with a range of different AMR 305	  
genes. Of note, ST101 from CG43 seems to be widely distributed in Europe and is 306	  
commonly associated with CTX-M-15, largely through plasmid acquisition 307	  
[46,70,97–100]. However, a genome sequence from a representative isolate of an 308	  
ST101 outbreak in Germany showed that this strain harboured a chromosomal copy of 309	  
the ISEcp1-CTX-M-15 transposon [46]. Isolates from this outbreak were resistant to 310	  
extended spectrum beta-lactams, gentamicin, tetracycline, ciprofloxacin and 311	  
sulphamethoxazole/trimethoprim and harboured CTX-M-15, TEM-1, and plasmid 312	  
replicons FIA and FIB. Aside from CTX-M-15, the location of the remaining AMR 313	  
genes was unclear [46]. This finding is potentially of concern given that the fitness 314	  
cost of chromosomal CTX-M-15 is likely much reduced compared to the cost of 315	  
maintenance of an entire CTX-M-15 plasmid. Consequently, it is more likely that the 316	  
host will retain the gene even in the absence of antimicrobial selective pressure. 317	  
Unfortunately, CG43 is not the only Kp AMR clone within which chromosomal CTX-318	  
M-15 has been reported. More worryingly, the genome of an ST147 isolate from the 319	  
United Arab Emirates contained a chromosomal ISEcp1-CTX-M-15 plus three 320	  
chromosomal copies of ISEcp1-OXA-181, which conferred resistance to the 321	  
carbapenems [47]. The situation was worsened by the fact that one of the ISEcp1-322	  
OXA-181 transposons had interrupted the mgrB gene, resulting in colistin resistance 323	  
and generating a truly pan-resistant strain [47].  324	  
 325	  
  326	  
	   13	  
Concluding Remarks and Future Perspectives  327	  
There is now widespread recognition of the immense potential for genomics to 328	  
enhance surveillance and tracking of specific pathogens and of AMR more generally, 329	  
and to aid infection control and outbreak investigations. Several studies have reported 330	  
the use of genomics to aid investigations of AMR Kp outbreaks in hospitals, with 331	  
emerging themes being the detection of persistent polyclonal outbreaks resulting from 332	  
transmission of AMR plasmids as well as AMR clones; asymptomatic colonisation of 333	  
healthcare workers and patients with AMR clones; and sinks, taps and drains as 334	  
persistent reservoirs of infection [17,22,42,43]. We contend that analysis and 335	  
interpretation of genome data generated in such studies will be greatly assisted in the 336	  
future by the emerging genomic framework for Kp, which helps investigators to 337	  
readily extract the most useful information and place it in the context of the existing 338	  
knowledge base. Currently the key elements of the Kp genomic framework are 339	  
identification of CGs; AMR determinants including acquired genes and common 340	  
mutations; known virulence genes and alleles; plasmids; and capsular and O antigen 341	  
loci. Details of current data sources and tools for extracting these elements from Kp 342	  
genome data are given in Box 1.  343	  
 344	  
While the availability of thousands of Kp genomes may sound ample to some, we 345	  
believe there is a pressing need to dramatically expand our current understanding of 346	  
the Kp population through further functional, clinical and ecological genomics 347	  
studies. Understanding of Kp disease, transmission and evolution is arguably decades 348	  
behind that of other human pathogens, but genomics can help scientists and clinicians 349	  
to rapidly advance our knowledge of this important threat to global health. Studies to 350	  
date show population structure of Kp is complex and intriguing, and raises important 351	  
questions about the functional and ecological differences between lineages, which are 352	  
highly relevant to understanding why certain Kp lineages appear to pose greater 353	  
clinical problems than others (see Outstanding Questions). Functional genomics 354	  
studies are needed to identify factors involved in environmental persistence of Kp, as 355	  
well as transmission, colonisation, and pathogenicity in humans [101]. Functional 356	  
genomics can also be used to search for lineage-specific factors that might explain 357	  
why certain AMR determinants appear to be maintained in some CGs but transient in 358	  
others [67,102], which could be novel targets for inhibition of the seemingly never-359	  
ending accumulation of AMR in the problem clones. Analysis of the available 360	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genome data indicates that the Kp sequenced so far represent the tip of the iceberg of 361	  
a much larger Kp population (Figure 1b, 2a). Much deeper sampling will be required 362	  
in order to begin to understand the ecology of Kp, which could identify important 363	  
reservoirs of bacterial diversity and help to understand why Kp appears to have so 364	  
often been the first step in the trafficking of AMR genes from environmental bacteria 365	  
into human-associated bacterial populations.  366	  
 367	  
After simmering away for decades, the problem of AMR Kp has become too 368	  
important to ignore and the international medical, public health and scientific 369	  
communities now need to play catch-up. Genomics has played a key role in the past 370	  
few years and has plenty more to offer in tackling the global threat of AMR Kp. 371	  
Given the scale of the challenge, it will be important to continue to build a deeper 372	  
understanding of the underlying population out of which problem clones emerge and 373	  
to share genomic data together with associated source and phenotypic data, in order to 374	  
maximize the potential benefits of genomic approaches.  375	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Figure Legends 376	  
 377	  
Figure 1. Lineage Diversity in Klebsiella pneumoniae. (a) Core gene phylogeny for 378	  
K. pneumoniae. Unrooted maximum likelihood phylogenetic tree for 283 isolates 379	  
sampled from diverse sources and locations, tips are coloured by country as indicated 380	  
in panel b. (b) Discovery of novel K. pneumoniae lineages with increasing sampling 381	  
of isolates in different locations. Curves show the discovery rate for new K. 382	  
pneumoniae lineages as more isolates were sampled for whole genome sequencing; 383	  
Simpson’s diversity index is shown in parentheses. Plots are reproduced from [16]; 384	  
tree and source information are available for interactive viewing at 385	  
https://microreact.org/project/BJClQz9H. 386	  
 387	  
Figure 2. Gene Content Diversity in Klebsiella pneumoniae. (a) K. pneumoniae pan 388	  
genome. Curves show the discovery rate for new K. pneumoniae protein-coding genes 389	  
as more isolates were sampled for whole genome sequencing (mean and 95% 390	  
confidence interval for each sample size). Different absolute numbers are obtained 391	  
depending on the level of amino acid (aa) identity used to define a new protein-coding 392	  
gene, however both curves show that the K. pneumoniae population has an open pan 393	  
genome, indicating there is no upper limit to the number of accessory genes that the 394	  
population can sustain. (b) Differences in gene content within and between K. 395	  
pneumoniae lineages. Boxplots show the distribution of gene content distances 396	  
(measured using Jaccard distance) for pairs of K. pneumoniae genomes that belong to 397	  
the same (blue) or different (green) lineages. Plots are reproduced from data in [16]. 398	  
 399	  
  400	  
	   16	  
Figure 3. Distribution of Klebsialla pneumoniae Outbreaks by Clonal Group 401	  
(CG) and Region. Outbreak reports as of June 2016 were identified in the literature 402	  
by PubMED search using the following search terms; “Klebsiella pneumoniae” AND 403	  
“outbreak” AND (one of “MLST” OR “multilocus sequence typing”); “Klebsiella 404	  
pneumoniae” AND “outbreak” AND (one of “ST1*” … “ST9*” OR “CG1*” ... 405	  
“CG9*” OR “CC1*” … “CC9*”). Pie graph areas are proportional to the total number 406	  
of outbreaks reported in each World Health Organization region (each region is 407	  
indicated by a different shade of grey), slices indicate frequency of each CG. CG 258 408	  
is divided into two categories; ST258 and its derivative ST512; and the remaining 409	  
sequence types (STs) identified in the literature search (ST11, ST340 and ST437). CG 410	  
14/15 includes ST14 and ST15; CG 17/20 includes ST16, ST17 and ST20; CG 43 411	  
includes ST101; CG 147 includes ST147 and ST273; other indicates outbreaks caused 412	  
by 22 different Kp STs that are not part of any named CG, one K. variicola ST and its 413	  
derivative (ST48 and ST1236, respectively) and one K. quasipneumoniae ST334. Red 414	  
stars indicate the locations of the earliest recorded ST258 outbreaks in the United 415	  
States and Israel, for which MLST was not applied. Blue star indicates the location of 416	  
the Nepalese ST15 outbreak, which did not meet the search criteria but is described in 417	  
the main text. 418	  
 419	  
Figure 4. Genomic Evolution of Klebsiella pneumoniae Clonal Group (CG) 258. 420	  
A schematic cladogram of the relationships within CG258 is shown alongside colour 421	  
bars that represent the bacterial chromosome. Coloured blocks represent regions of 422	  
the genome acquired through horizontal transfer from a K. pneumoniae that is not part 423	  
of CG258, as indicated by the arrows. The relative positions of the seven K. 424	  
pneumoniae multi-locus sequence typing loci are indicated by grey pointers. The 425	  
position of the K locus is indicated by an orange pointer. ST258 lineage I and II are 426	  
labelled ST258-I and ST258-II, respectively.  427	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Table 1. Genetic Determinants of AMR in Klebsiella pneumoniae Genomes. 428	  
 429	  
Beta-lactamases  bla genes conferring resistance (*intrinsic) 
Class A  CARB-3, PSE-1, SCO-1, SHV-1*, TEM-1 
 - ESBL CTX-M, SHV-5, TEM-10, VEB 
 - Carbapenemase KPC, GES-5 
Class B  
  (Metallo-beta-lactamase) CphA, IMP, NDM, SIM, VIM 
Class C  
  (Cephalosporinase) AmpC, CMY, DHA, FOX, MIR 
Class D OXA-1, OXA-2, OXA-7, OXA-9, OXA-10, OXA-12 
 - ESBL OXA-11, OXA-15 
 - Carbapenemase OXA-48, OXA-51, OXA-181, OXA-237 
Other AMR Genes conferring resistance (*intrinsic) Mutations 
Aminoglycosides aac, aadA, aadB, aph, armA, rmt, strAB - 
Carbapenems 
(see carbapenemase bla 
genes, class A & D 
above) 
Mutations in ompK35, 
ompK36 
Colistin mcr-1, mcr1.2 Inactivation of pmrB, mgrB; mutations in crrB  
Fluoroquinolones qepA, qnrA, qnrB, qnrD, qnrS, qepA 
SNPs in gyrA, parC; 
Upregulation of acrAB or 
oqxAB efflux 
Macrolides ereA, ereB, ermB, mef, mph, msrE  - 
Phenicols catA, catB, cml, floR - 
Rifampin arr   
Sulfonamides folP, sul1, sul2, sul3 - 
Tetracycline tet genes - 
Tigecycline - 
Upregulation of acrAB or 
oqxAB efflux; mutation in 
rpsJ 
Trimethoprim dfr genes - 
  430	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Box 1. Tools and Databases for K. pneumoniae Genomic Analyses. 431	  
• Klebsiella pneumoniae BIGSdb: An online database and integrated set of tools for 432	  
analysis of genome assemblies [14]. The K. pneumoniae MLST database, 433	  
cgMLST, virulence and resistance gene databases are available through this single 434	  
resource, which also hosts a searchable repository of K. pneumoniae, K. variicola 435	  
and K. quasipneumoniae genomes. As of June 2016 the database includes 2328 436	  
distinct STs. Available at bigsdb.pasteur.fr/klebsiella. 437	  
• Centre for Genomic Epidemiology: A suite of online tools for analysis of 438	  
genome assemblies or short read data. K. pneumoniae MLST analysis [103], 439	  
virulence and AMR gene screening [104,105], and plasmid screening [106] are all 440	  
available. The AMR screening protocol uses the ResFinder database [105]. 441	  
Available at www.genomicepidemiology.org. 442	  
• SRST2: An offline tool for allelic typing from short read sequence data [107]. 443	  
MLST, virulence and resistance gene screening can be achieved directly from 444	  
sequence reads. In fact, SRST2 can be used in conjunction with any appropriately 445	  
formatted gene or allelic database. Available at github.com/katholt/srst2. 446	  
• ISmapper: An offline tool for determination of insertion sequences (IS), copy 447	  
number and insertion sites within genomes [108]. ISmapper takes as input paired-448	  
end short read sequence data, a genome assembly or reference genome and a set of 449	  
IS references. Available at github.com/jhawkey/IS_mapper. 450	  
• ISfinder: A searchable online database of bacterial IS. Users can access and/or 451	  
download IS nucleotide sequences and relevant information, including general 452	  
features, direct and inverted repeat sequences and predicted protein sequences.  453	  
There is a BLASTn query function, a list of IS annotated bacterial genomes and a 454	  
browser for visualisation of IS within genomes. Available at www-is.biotoul.fr. 455	  
• Kaptive: A database of complete sequences of Klebsiella capsule loci and 456	  
accompanying tool for identification and typing of capsule loci from genome 457	  
assemblies. Available at github.com/katholt/kaptive. 458	  
• NCBI Pathogen Detection resources: Curated databases of AMR genes and 459	  
genomes of antimicrobial resistant bacterial pathogens. As at June 2016 the 460	  
databases include 3,275 AMR gene nucleotide sequences and 2,391 annotated 461	  
genomes drawn from Genbank. Genome-wide phylogenetic analyses, pre-462	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computed at the species level, can also be accessed. Available at 463	  
www.ncbi.nlm.nih.gov/pathogens. 464	  
• PATRIC database: An integrated resource for analysis and exploration of 465	  
pathogen genomes including Klebsiella. Users can access and download hundreds 466	  
of Klebsiella genome assemblies with accompanying annotation and source 467	  
information. Protein sorting and metabolic pathway comparison tools are also 468	  
included. Available at www.patricbrc.org.   469	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